Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI

NCT06490562 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
66
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China